EIGEN / USDC

EIGEN / USDT

EIGEN / FDUSD

EIGEN / TRY

EIGEN / BTC

BABY / USDT

BABY / USDC

BABY / TRY

EPIC / USDC

EPIC / USDT

SPK / FDUSD

KMNO / USDT

KMNO / USDC

SPK / BNB

PEOPLE / BTC

NIL / BNB

HOT / ETH

PROM / USDT

ROSE / BTC

CYBER / BNB

INTENSE TECHNOLOGIES LTD

STL NETWORKS LIMITED

DEEPAK BUILDERS & ENG I L

SHARP CHUCKS N MACHINES L

IRM ENERGY LIMITED

GTL LTD

AKASH INFRA-PROJECTS LTD

PRISM JOHNSON LIMITED

POONAWALLA FINCORP LTD

BANCO PRODUCTS (I) LTD

ZYDUS WELLNESS LIMITED

QUICKTOUCH TECHNOLOGIES L

PRANIK LOGISTICS LIMITED

SUNDARAM FINANCE HOLD LTD

COHANCE LIFESCIENCES LTD

SHUBHSHREE BIOFUELS ENE L

XPRO INDIA LIMITED

SHRI HARE-KRI SPO IRON L

INFOMEDIA PRESS LIMITED

MOHIT INDUSTRIES LTD

Click here to get full coverage on Cohance Lifesciences Stock Tanks On ₹3,000 Crore Promoter Stake Sale - Stocktwits

Cohance Lifesciences Stock Tanks On ₹3,000 Crore Promoter Stake Sale  Stocktwits

Cohance Lifesciences Stock Tanks On ₹3,000 Crore Promoter Stake Sale - Stocktwits

Click here to get full coverage on Cohance Lifesciences shares worth ₹3,073 crore change hands in block deals; Stock falls 6% - CNBC TV18

Cohance Lifesciences shares worth ₹3,073 crore change hands in block deals; Stock falls 6%  CNBC TV18

Cohance Lifesciences shares worth ₹3,073 crore change hands in block deals; Stock falls 6% - CNBC TV18

Click here to get full coverage on India's Cohance falls on discounted block deal - TradingView

India's Cohance falls on discounted block deal  TradingView

India's Cohance falls on discounted block deal - TradingView

Click here to get full coverage on Cohance Lifesciences Faces Significant Decline Amid Broader Market Gains - Markets Mojo

Cohance Lifesciences Faces Significant Decline Amid Broader Market Gains  Markets Mojo

Cohance Lifesciences Faces Significant Decline Amid Broader Market Gains - Markets Mojo

Click here to get full coverage on Cohance Life shares tumble 6% as 3.4 crore shares exchange hands via block deal - Moneycontrol

Cohance Life shares tumble 6% as 3.4 crore shares exchange hands via block deal  Moneycontrol

Cohance Life shares tumble 6% as 3.4 crore shares exchange hands via block deal - Moneycontrol

Click here to get full coverage on Cohance Lifesciences Block Deal: Promoter Likely To Offload Rs 1,756-Crore Stake - NDTV Profit

Cohance Lifesciences Block Deal: Promoter Likely To Offload Rs 1,756-Crore Stake  NDTV Profit

Cohance Lifesciences Block Deal: Promoter Likely To Offload Rs 1,756-Crore Stake - NDTV Profit

Click here to get full coverage on Top stocks in news: Cohance, Indosolar, Dixon Tech, Federal Bank, Cochin Shipyard, Biocon - MSN

Top stocks in news: Cohance, Indosolar, Dixon Tech, Federal Bank, Cochin Shipyard, Biocon  MSN

Top stocks in news: Cohance, Indosolar, Dixon Tech, Federal Bank, Cochin Shipyard, Biocon - MSN

Click here to get full coverage on COHANCE LIFESCIENCES Share Price Today Down 5% - Equitymaster

COHANCE LIFESCIENCES Share Price Today Down 5%  Equitymaster

COHANCE LIFESCIENCES Share Price Today Down 5% - Equitymaster

Click here to get full coverage on Cohance Lifesciences API plant clears FDA inspection with zero observations - Indiatimes

Cohance Lifesciences API plant clears FDA inspection with zero observations  Indiatimes

Cohance Lifesciences API plant clears FDA inspection with zero observations - Indiatimes

Click here to get full coverage on Cohance Lifesciences shares drop over 5% on heavy volumes - Upstox

Cohance Lifesciences shares drop over 5% on heavy volumes  Upstox

Cohance Lifesciences shares drop over 5% on heavy volumes - Upstox

Click here to get full coverage on Cohance Lifesciences announces $10 million investment in US-based arm - The Economic Times

Cohance Lifesciences announces $10 million investment in US-based arm  The Economic Times

Cohance Lifesciences announces $10 million investment in US-based arm - The Economic Times

Click here to get full coverage on Jefferies initiates coverage on Cohance Lifesciences stock with Buy rating - Investing.com

Jefferies initiates coverage on Cohance Lifesciences stock with Buy rating  Investing.com

Jefferies initiates coverage on Cohance Lifesciences stock with Buy rating - Investing.com

Click here to get full coverage on Stocks to Watch Today: Cohance Lifesciences, Indosolar, Biocon, Cochin Shipyard, Dixon Technologies,... - Moneycontrol

Stocks to Watch Today: Cohance Lifesciences, Indosolar, Biocon, Cochin Shipyard, Dixon Technologies,...  Moneycontrol

Stocks to Watch Today: Cohance Lifesciences, Indosolar, Biocon, Cochin Shipyard, Dixon Technologies,... - Moneycontrol

Click here to get full coverage on Divi’s, Cohance, Sai Life among Jefferies’ top picks in pharma sector; Laurus Labs rated underperform - MSN

Divi’s, Cohance, Sai Life among Jefferies’ top picks in pharma sector; Laurus Labs rated underperform  MSN

Divi’s, Cohance, Sai Life among Jefferies’ top picks in pharma sector; Laurus Labs rated underperform - MSN

Click here to get full coverage on Jusmiral Holdings to sell up to 5.1% stake in Cohance Lifesciences via block deal: Sources - CNBC TV18

Jusmiral Holdings to sell up to 5.1% stake in Cohance Lifesciences via block deal: Sources  CNBC TV18

Jusmiral Holdings to sell up to 5.1% stake in Cohance Lifesciences via block deal: Sources - CNBC TV18

Click here to get full coverage on Cohance Lifesciences appoints Yann D'Herve as CEO of CDMO Business, effective August 1, 2025 - ET Edge - ET Edge Insights

Cohance Lifesciences appoints Yann D'Herve as CEO of CDMO Business, effective August 1, 2025 - ET Edge  ET Edge Insights

Cohance Lifesciences appoints Yann D'Herve as CEO of CDMO Business, effective August 1, 2025 - ET Edge - ET Edge Insights

Click here to get full coverage on Suven-Cohance merger done - Speciality Chemicals Magazine

Suven-Cohance merger done  Speciality Chemicals Magazine

Suven-Cohance merger done - Speciality Chemicals Magazine

Click here to get full coverage on Cohance Lifesciences to sell CR Bio assets to Chromo Laboratories India for Rs. 16 Cr - Indian Pharma Post

Cohance Lifesciences to sell CR Bio assets to Chromo Laboratories India for Rs. 16 Cr  Indian Pharma Post

Cohance Lifesciences to sell CR Bio assets to Chromo Laboratories India for Rs. 16 Cr - Indian Pharma Post

Click here to get full coverage on Cohance Lifesciences Shares In Focus As Jefferies Initiates Coverage With Buy Rating: Check Target Price - NDTV Profit

Cohance Lifesciences Shares In Focus As Jefferies Initiates Coverage With Buy Rating: Check Target Price  NDTV Profit

Cohance Lifesciences Shares In Focus As Jefferies Initiates Coverage With Buy Rating: Check Target Price - NDTV Profit

Click here to get full coverage on Yann D’Herve joins Cohance Lifesciences as CEO – CDMO Business - BioSpectrum India

Yann D’Herve joins Cohance Lifesciences as CEO – CDMO Business  BioSpectrum India

Yann D’Herve joins Cohance Lifesciences as CEO – CDMO Business - BioSpectrum India

Click here to get full coverage on Stocks To Buy: Jefferies initiates on this contract manufacturer for 30% upside, upgrades Divi's - CNBC TV18

Stocks To Buy: Jefferies initiates on this contract manufacturer for 30% upside, upgrades Divi's  CNBC TV18

Stocks To Buy: Jefferies initiates on this contract manufacturer for 30% upside, upgrades Divi's - CNBC TV18

Click here to get full coverage on Block Deal: Pharma stock falls over 5% as promoter likely to sell 5.1% stake worth ₹1,756 - Trade Brains

Block Deal: Pharma stock falls over 5% as promoter likely to sell 5.1% stake worth ₹1,756  Trade Brains

Block Deal: Pharma stock falls over 5% as promoter likely to sell 5.1% stake worth ₹1,756 - Trade Brains

Click here to get full coverage on AMFI Reshuffle: Poonawalla Fincorp, Gillette India among 6 smallcap stocks that may get midcap status - The Economic Times

AMFI Reshuffle: Poonawalla Fincorp, Gillette India among 6 smallcap stocks that may get midcap status  The Economic Times

AMFI Reshuffle: Poonawalla Fincorp, Gillette India among 6 smallcap stocks that may get midcap status - The Economic Times

Click here to get full coverage on Divi’s, Piramal Pharma to Sai Life: Jefferies lists four pharma stocks to buy for up to 30% gains. Do you own any? - Mint

Divi’s, Piramal Pharma to Sai Life: Jefferies lists four pharma stocks to buy for up to 30% gains. Do you own any?  Mint

Divi’s, Piramal Pharma to Sai Life: Jefferies lists four pharma stocks to buy for up to 30% gains. Do you own any? - Mint

Click here to get full coverage on Suven Pharmaceuticals is now Cohance Lifesciences - Indian Pharma Post

Suven Pharmaceuticals is now Cohance Lifesciences  Indian Pharma Post

Suven Pharmaceuticals is now Cohance Lifesciences - Indian Pharma Post

Click here to get full coverage on Cohance to invest $10 million to expand capabilities of U.S. arm, ₹23 cr. in new facility at Hyderabad - The Hindu

Cohance to invest $10 million to expand capabilities of U.S. arm, ₹23 cr. in new facility at Hyderabad  The Hindu

Cohance to invest $10 million to expand capabilities of U.S. arm, ₹23 cr. in new facility at Hyderabad - The Hindu

Click here to get full coverage on Cohance Lifesciences and other pharma stocks jump up to 5% after Jefferies initiates Buy recommendation - The Economic Times

Cohance Lifesciences and other pharma stocks jump up to 5% after Jefferies initiates Buy recommendation  The Economic Times

Cohance Lifesciences and other pharma stocks jump up to 5% after Jefferies initiates Buy recommendation - The Economic Times

Click here to get full coverage on Cohance Lifesciences names Yann D’Herve as next CEO for CDMO biz - Indiatimes

Cohance Lifesciences names Yann D’Herve as next CEO for CDMO biz  Indiatimes

Cohance Lifesciences names Yann D’Herve as next CEO for CDMO biz - Indiatimes

Click here to get full coverage on Cohance Lifesciences Shows Strong Short-Term Gains Amid Mixed Market Performance - Markets Mojo

Cohance Lifesciences Shows Strong Short-Term Gains Amid Mixed Market Performance  Markets Mojo

Cohance Lifesciences Shows Strong Short-Term Gains Amid Mixed Market Performance - Markets Mojo

Click here to get full coverage on Cohance Lifesciences announces USD 10 mn investment in cGMP Bioconjugation Suite at NJ Bio - Medical Dialogues

Cohance Lifesciences announces USD 10 mn investment in cGMP Bioconjugation Suite at NJ Bio  Medical Dialogues

Cohance Lifesciences announces USD 10 mn investment in cGMP Bioconjugation Suite at NJ Bio - Medical Dialogues

Click here to get full coverage on cohance lifesciences andhra pradesh facility clears usfda cgmp inspection with zero observations - Capital Market

cohance lifesciences andhra pradesh facility clears usfda cgmp inspection with zero observations  Capital Market

cohance lifesciences andhra pradesh facility clears usfda cgmp inspection with zero observations - Capital Market

Click here to get full coverage on Cohance Invests Rs 23 Crore In Oligonucleotide Building Block Manufacturing Facility in Hyderabad - Deccan Chronicle

Cohance Invests Rs 23 Crore In Oligonucleotide Building Block Manufacturing Facility in Hyderabad  Deccan Chronicle

Cohance Invests Rs 23 Crore In Oligonucleotide Building Block Manufacturing Facility in Hyderabad - Deccan Chronicle

Click here to get full coverage on Cohance to invest Rs 110 crore in new facilities in Hyderabad and New Jersey - Times of India

Cohance to invest Rs 110 crore in new facilities in Hyderabad and New Jersey  Times of India

Cohance to invest Rs 110 crore in new facilities in Hyderabad and New Jersey - Times of India

Click here to get full coverage on Stocks in Focus: Gujarat Fluorochem, Pitti Engineering, Dreamfolks, Lodha Developers, Cochin Shipyard, ONGC, Adani Enterprises, TVS Motor, Thomas Cook, Hyundai, Biocon - BusinessLine

Stocks in Focus: Gujarat Fluorochem, Pitti Engineering, Dreamfolks, Lodha Developers, Cochin Shipyard, ONGC, Adani Enterprises, TVS Motor, Thomas Cook, Hyundai, Biocon  BusinessLine

Stocks in Focus: Gujarat Fluorochem, Pitti Engineering, Dreamfolks, Lodha Developers, Cochin Shipyard, ONGC, Adani Enterprises, TVS Motor, Thomas Cook, Hyundai, Biocon - BusinessLine

Click here to get full coverage on Stocks to buy in 2025 for long term: Cohance Lifesciences, Divi’s Lab among 5 stocks that could give 10-30% return - The Economic Times

Stocks to buy in 2025 for long term: Cohance Lifesciences, Divi’s Lab among 5 stocks that could give 10-30% return  The Economic Times

Stocks to buy in 2025 for long term: Cohance Lifesciences, Divi’s Lab among 5 stocks that could give 10-30% return - The Economic Times

Click here to get full coverage on USFDA concludes audit at Cohance Lifesciences Jaggaiahpet facility - Medical Dialogues

USFDA concludes audit at Cohance Lifesciences Jaggaiahpet facility  Medical Dialogues

USFDA concludes audit at Cohance Lifesciences Jaggaiahpet facility - Medical Dialogues

Click here to get full coverage on Cohance Lifesciences’ facility completes USFDA audit - BusinessLine

Cohance Lifesciences’ facility completes USFDA audit  BusinessLine

Cohance Lifesciences’ facility completes USFDA audit - BusinessLine

Click here to get full coverage on Cohance Lifesciences Announces ₹230 mn Investment and Progress on cGMP Oligonucleotide Facility at... - The Hans India

Cohance Lifesciences Announces ₹230 mn Investment and Progress on cGMP Oligonucleotide Facility at...  The Hans India

Cohance Lifesciences Announces ₹230 mn Investment and Progress on cGMP Oligonucleotide Facility at... - The Hans India

Click here to get full coverage on Cohance Lifesciences to invest close to ₹100 Cr in capacity expansion - Indiatimes

Cohance Lifesciences to invest close to ₹100 Cr in capacity expansion  Indiatimes

Cohance Lifesciences to invest close to ₹100 Cr in capacity expansion - Indiatimes

Click here to get full coverage on Jefferies upbeat on India CRDMO; initiates Buy on Cohance; upgrades Divi's - Business Standard

Jefferies upbeat on India CRDMO; initiates Buy on Cohance; upgrades Divi's  Business Standard

Jefferies upbeat on India CRDMO; initiates Buy on Cohance; upgrades Divi's - Business Standard

Click here to get full coverage on Cohance Lifesciences reports 13% revenue growth in Q1 FY26 - Indian Pharma Post

Cohance Lifesciences reports 13% revenue growth in Q1 FY26  Indian Pharma Post

Cohance Lifesciences reports 13% revenue growth in Q1 FY26 - Indian Pharma Post

Click here to get full coverage on India Can Lead the Complex CDMO Revolution: Cohance Chairman Bets Big on ADCs and Oligos - Indiatimes

India Can Lead the Complex CDMO Revolution: Cohance Chairman Bets Big on ADCs and Oligos  Indiatimes

India Can Lead the Complex CDMO Revolution: Cohance Chairman Bets Big on ADCs and Oligos - Indiatimes

Click here to get full coverage on Cohance Lifesciences' API unit 1 completes USFDA inspection - Capital Market

Cohance Lifesciences' API unit 1 completes USFDA inspection  Capital Market

Cohance Lifesciences' API unit 1 completes USFDA inspection - Capital Market

Click here to get full coverage on Cohance Lifesciences Hits 52-Week Low Amid Mixed Financial Performance and High Valuation Concerns - Markets Mojo

Cohance Lifesciences Hits 52-Week Low Amid Mixed Financial Performance and High Valuation Concerns  Markets Mojo

Cohance Lifesciences Hits 52-Week Low Amid Mixed Financial Performance and High Valuation Concerns - Markets Mojo

Click here to get full coverage on Cohance Lifesciences announces $10 M investment in cGMP Bioconjugation Suite in US - BioSpectrum India

Cohance Lifesciences announces $10 M investment in cGMP Bioconjugation Suite in US  BioSpectrum India

Cohance Lifesciences announces $10 M investment in cGMP Bioconjugation Suite in US - BioSpectrum India

Click here to get full coverage on Cohance Lifesciences shares surge 6% as Jefferies initiates coverage - Business Today

Cohance Lifesciences shares surge 6% as Jefferies initiates coverage  Business Today

Cohance Lifesciences shares surge 6% as Jefferies initiates coverage - Business Today

Click here to get full coverage on Cohance to invest Rs. 23 crore on cGMP Oligonucleotide facility at Hyderabad - Indian Pharma Post

Cohance to invest Rs. 23 crore on cGMP Oligonucleotide facility at Hyderabad  Indian Pharma Post

Cohance to invest Rs. 23 crore on cGMP Oligonucleotide facility at Hyderabad - Indian Pharma Post

Click here to get full coverage on Cohance Lifesciences Faces Potential Trend Reversal Amid Broader Market Stability - Markets Mojo

Cohance Lifesciences Faces Potential Trend Reversal Amid Broader Market Stability  Markets Mojo

Cohance Lifesciences Faces Potential Trend Reversal Amid Broader Market Stability - Markets Mojo

Click here to get full coverage on Cohance Lifesciences Hits 52-Week Low Amid Broader Market Decline and Pledged Shares - Markets Mojo

Cohance Lifesciences Hits 52-Week Low Amid Broader Market Decline and Pledged Shares  Markets Mojo

Cohance Lifesciences Hits 52-Week Low Amid Broader Market Decline and Pledged Shares - Markets Mojo

Click here to get full coverage on Cohance Lifesciences Hits 52-Week Low Amidst Declining Stock Performance and Pledged Shares - Markets Mojo

Cohance Lifesciences Hits 52-Week Low Amidst Declining Stock Performance and Pledged Shares  Markets Mojo

Cohance Lifesciences Hits 52-Week Low Amidst Declining Stock Performance and Pledged Shares - Markets Mojo

Click here to get full coverage on Laurus Labs, Piramal, Divis, Sai Life, Cohance: Jefferies tests interest in CRDMO stocks - Business Today

Laurus Labs, Piramal, Divis, Sai Life, Cohance: Jefferies tests interest in CRDMO stocks  Business Today

Laurus Labs, Piramal, Divis, Sai Life, Cohance: Jefferies tests interest in CRDMO stocks - Business Today

Click here to get full coverage on Cohance Lifesciences announces ₹230 mn investment and progress on cGMP Oligonucleotide facility at Hyderabad - Express Pharma

Cohance Lifesciences announces ₹230 mn investment and progress on cGMP Oligonucleotide facility at Hyderabad  Express Pharma

Cohance Lifesciences announces ₹230 mn investment and progress on cGMP Oligonucleotide facility at Hyderabad - Express Pharma

Click here to get full coverage on Cohance Lifesciences Faces Potential Trend Reversal Amid Recent Stock Decline - Markets Mojo

Cohance Lifesciences Faces Potential Trend Reversal Amid Recent Stock Decline  Markets Mojo

Cohance Lifesciences Faces Potential Trend Reversal Amid Recent Stock Decline - Markets Mojo

Click here to get full coverage on Cohance Lifesciences announces USD 10 mn investment in US-based arm - Press Trust of India

Cohance Lifesciences announces USD 10 mn investment in US-based arm  Press Trust of India

COHANCE (COHANCE)

Price Chart

Key Statistics

Technicals

About COHANCE

Latest News

Cohance Lifesciences Stock Tanks On ₹3,000 Crore Promoter Stake Sale - Stocktwits

Cohance Lifesciences shares worth ₹3,073 crore change hands in block deals; Stock falls 6% - CNBC TV18

India's Cohance falls on discounted block deal - TradingView

Advanced Charts

Top Gainers

Top Losers